NTV Northern 2 Vct Plc

 
TIDMNTV 
 
22 SEPTEMBER 2009 
 
NORTHERN 2 VCT PLC 
 
PORTFOLIO UPDATE 
 
 
Northern 2 VCT PLC ("the Company") announces the sale of its 
investment in DxS Limited, which provides molecular diagnostic 
products and services to the healthcare industry, for initial cash 
proceeds of GBP4.4 million, plus GBP0.6 million by way of accrued loan 
stock interest and preference dividends.  The Company may become 
entitled to receive up to a further GBP3.2 million over the period to 
2012 subject to the achievement by DxS of specified objectives. 
 
The initial sale price has been reflected in the directors' valuation 
of the investment in DxS as at 31 July 2009 as shown in the unaudited 
half-yearly results for the six months ended 31 July 2009, which have 
been announced by the Company today. 
 
The Company invested a total of GBP0.7 million in DxS in a series of 
early-stage funding rounds led by NVM Private Equity between 2001 and 
2006.  The total income and capital proceeds to date (excluding 
contingent future payments) represent a money multiple of 7.5 times 
the original investment and an internal rate of return (IRR) of 31.7% 
per annum. 
 
 
Enquiries: 
 
Tim Levett/Christopher Mellor, NVM Private Equity Limited - 0191 244 
6000 
 
=--END OF MESSAGE--- 
 
 
 
 
This announcement was originally distributed by Hugin. The issuer is 
solely responsible for the content of this announcement. 
 

Northern 2 Vct (LSE:NTV)
Historical Stock Chart
From Jun 2024 to Jul 2024

Northern 2 Vct (LSE:NTV)
Historical Stock Chart
From Jul 2023 to Jul 2024